What We're Reading: Page 336
Industry reads hand-picked by our editors
Jan 27, 2016
Jan 26, 2016
-
Reuters
Galapagos bowel drug fails in research trial
-
Benzinga
Actelion wins Canadian approval for Uptravi
-
Wall Street Journal
Researchers try to solve puzzle of heart disease risk disparities
Jan 25, 2016
-
Wall Street Journal
Valeant's Pearson: 'On the Road to Recovery'
-
Bloomberg
Shkreli Gets Snow Day as Congress Delays Hearing After Storm
-
PharmaTimes
NHS missed out on £54 million generic Lyrica savings
-
The Economic Times
Torrent, Dr Reddy’s, Aurobindo, Cipla, Lupin in race to buy Sagent
Jan 22, 2016
Jan 21, 2016
-
Reuters
GSK Chief reiterates standalone consumer unit is an option
-
Fierce Biotech
'I have constitutional rights,' tweets Martin Shkreli, defying Senate subpoena
-
Wall Street Journal
Muscular Dystrophy Drugs Face New FDA Questions
-
In-Pharmatechnologist
Drugmakers: Government purchasing commitments would encourge antibiotics R&D
Previous
